Strength training for eye melanoma survivors
Part of Cancer, Eyes & vision clinical trials.
This trial tests whether a high intensity resistance (strength) training program can help people who have been treated for choroidal melanoma (an eye cancer) with plaque brachytherapy. The goal is to improve muscle strength and overall health after cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with choroidal melanoma (a type of eye cancer) and treated with plaque brachytherapy (a type of radiation therapy) at Hospital La Fe in Valencia, Spain.
- You are an adult (18 years or older).
- Your health allows you to safely do high intensity strength training (like lifting weights).
- You do not have unstable heart disease, a serious metabolic disorder (like poorly controlled diabetes), or a major orthopedic issue (like a bone or joint problem) that would make exercise unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a moderate-intensity exercise program helps adults with melanoma who are receiving chemotherapy before surgery. It aims to improve recovery and well-being during treatment.
This trial tests if a supervised exercise program can help reduce symptoms like fatigue and improve well-being in people with advanced melanoma who are already on immunotherapy or targeted therapy. You would visit the study hospital for training sessions and check-ups.
This trial looks at whether adding a program of exercise and nutrition changes can improve quality of life and treatment outcomes for people with melanoma who are starting immunotherapy. If you qualify, you would take part in a structured plan to see if these lifestyle changes help.
This study tests a personalized exercise program using resistance training (lifting weights) to help cancer survivors rebuild strength, improve body composition, and move better after treatment. It is designed for people who are ready to start exercising safely and want to regain function.
This trial tests whether an adapted physical activity program can help patients with advanced melanoma who are receiving immunotherapy or targeted therapy. It aims to support overall well-being during treatment.
This early-phase study tests whether melphalan can be used to reduce (shrink) a type of eye cancer called choroidal melanoma before additional treatment. It may help by controlling tumor size while doctors closely monitor the eye and outcomes.
Hear when a new Ocular Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.